NCTN Assessment on Current Applications of Radiomics in Oncology

Ke Nie, Hania Al-Hallaq, X. Allen Li, Stanley H Benedict, Jason W. Sohn, Jean M. Moran, Yong Fan, Mi Huang, Michael V. Knopp, Jeff M. Michalski, James Monroe, Ceferino Obcemea, Christina I. Tsien, Timothy Solberg, Jackie Wu, Ping Xia, Ying Xiao, Issam El Naqa

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

Radiomics is a fast-growing research area based on converting standard-of-care imaging into quantitative minable data and building subsequent predictive models to personalize treatment. Radiomics has been proposed as a study objective in clinical trial concepts and a potential biomarker for stratifying patients across interventional treatment arms. In recognizing the growing importance of radiomics in oncology, a group of medical physicists and clinicians from NRG Oncology reviewed the current status of the field and identified critical issues, providing a general assessment and early recommendations for incorporation in oncology studies.

Original languageEnglish (US)
Pages (from-to)302-315
Number of pages14
JournalInternational Journal of Radiation Oncology Biology Physics
Volume104
Issue number2
DOIs
StatePublished - Jun 1 2019

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'NCTN Assessment on Current Applications of Radiomics in Oncology'. Together they form a unique fingerprint.

  • Cite this

    Nie, K., Al-Hallaq, H., Li, X. A., Benedict, S. H., Sohn, J. W., Moran, J. M., Fan, Y., Huang, M., Knopp, M. V., Michalski, J. M., Monroe, J., Obcemea, C., Tsien, C. I., Solberg, T., Wu, J., Xia, P., Xiao, Y., & El Naqa, I. (2019). NCTN Assessment on Current Applications of Radiomics in Oncology. International Journal of Radiation Oncology Biology Physics, 104(2), 302-315. https://doi.org/10.1016/j.ijrobp.2019.01.087